Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.

Huang X, Liu F, Zhu C, Cai J, Wang H, Wang X, He S, Liu C, Yao L, Ding Z, Zhang Y, Zhang T.

Dig Dis Sci. 2014 Apr;59(4):795-806. doi: 10.1007/s10620-013-2969-2. Epub 2013 Dec 25.

2.

Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.

Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.

World J Gastroenterol. 2015 Apr 7;21(13):3983-93. doi: 10.3748/wjg.v21.i13.3983.

3.

Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.

Li C, Wu M, Zong G, Wan C, Liu Q, Zhou H, Hua L, Chen Y, Chen X, Lu C.

Dig Dis Sci. 2017 Jan;62(1):133-142. doi: 10.1007/s10620-016-4365-1. Epub 2016 Dec 5.

PMID:
27921263
4.

Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.

Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, Chen B, Shi W.

Dig Dis Sci. 2015 Nov;60(11):3351-63. doi: 10.1007/s10620-015-3774-x. Epub 2015 Jun 30.

PMID:
26123838
5.

A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.

Zhu P, Jin J, Liao Y, Li J, Yu XZ, Liao W, He S.

Oncotarget. 2015 Dec 1;6(38):41383-97. doi: 10.18632/oncotarget.5510.

6.

Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.

Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY.

World J Gastroenterol. 2015 Jul 28;21(28):8588-604. doi: 10.3748/wjg.v21.i28.8588.

7.

A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.

Liu F, Zhu C, Huang X, Cai J, Wang H, Wang X, He S, Liu C, Yang X, Zhang Y, Zhang T.

Pathol Res Pract. 2014 Dec;210(12):885-92. doi: 10.1016/j.prp.2014.07.011. Epub 2014 Aug 9.

PMID:
25169131
8.

Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.

Qiu H, Zhang X, Ni W, Shi W, Fan H, Xu J, Chen Y, Ni R, Tao T.

Dig Dis Sci. 2016 Mar;61(3):795-805. doi: 10.1007/s10620-015-3937-9. Epub 2015 Nov 9.

PMID:
26553251
9.

Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression.

Hu B, Yan X, Liu F, Zhu C, Zhou H, Chen Y, Liu J, Gu X, Ni R, Zhang T.

Pathol Oncol Res. 2016 Jul;22(3):555-65. doi: 10.1007/s12253-015-0038-1. Epub 2015 Dec 29.

PMID:
26715439
10.

Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.

Chen Y, Yang S, Hu J, Yu C, He M, Cai Z.

PLoS One. 2016 May 16;11(5):e0154939. doi: 10.1371/journal.pone.0154939. eCollection 2016.

11.

The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.

Zhang T, Wan C, Shi W, Xu J, Fan H, Zhang S, Lin Z, Ni R, Zhang X.

J Mol Histol. 2015 Dec;46(6):485-97. doi: 10.1007/s10735-015-9639-y. Epub 2015 Oct 5.

PMID:
26438629
12.

Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.

Shi W, Huang W, Chen Y, Zhang S, Xu P, Gu X, Fan H, Xu J, Chen Y, Ni R, Lu C, Zhang X.

Tumour Biol. 2016 Aug;37(8):10447-57. doi: 10.1007/s13277-015-4556-y. Epub 2016 Feb 5.

PMID:
26846109
13.
14.

CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.

Zong G, Xu Z, Zhang S, Shen Y, Qiu H, Zhu G, He S, Tao T, Chen X.

Dig Dis Sci. 2016 Aug;61(8):2303-14. doi: 10.1007/s10620-016-4149-7. Epub 2016 Apr 13.

PMID:
27074923
15.

Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.

Dai B, Ruan B, Wu J, Wang J, Shang R, Sun W, Li X, Dou K, Wang D, Li Y.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):5645-54. eCollection 2014.

16.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

17.

Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.

Zhang S, Shi W, Chen Y, Xu Z, Zhu J, Zhang T, Huang W, Ni R, Lu C, Zhang X.

Mol Cell Biochem. 2015 Dec;410(1-2):1-9. doi: 10.1007/s11010-015-2533-9. Epub 2015 Aug 11.

PMID:
26260052
18.

Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).

Zhao Y, Tang Q, Ni R, Huang X, Wang Y, Lu C, Shen A, Wang Y, Li C, Yuan Q, Chen H, Cheng C, He S.

Hum Pathol. 2013 Mar;44(3):365-73. doi: 10.1016/j.humpath.2012.03.030. Epub 2012 Sep 17.

PMID:
22995332
19.

General transcription factor IIb overexpression and a potential link to proliferation in human hepatocellular carcinoma.

Li L, Zhang A, Cao X, Chen J, Xia Y, Zhao H, Shen A.

Pathol Oncol Res. 2013 Apr;19(2):195-203. doi: 10.1007/s12253-012-9569-x. Epub 2012 Oct 5.

PMID:
23055019
20.

Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.

Chen HW, Huang XD, Li HC, He S, Ni RZ, Chen CH, Peng C, Wu G, Wang GH, Wang YY, Zhao YH, Zhang YX, Shen AG, Wang HM.

Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4.

PMID:
22488567

Supplemental Content

Support Center